GAROFALO ELIZABETH A.
SEC CIK 1826361 · EDGAR
BoughtSold
Most active insiders at ALEC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rosenthal Arnon | CEO, Dir | — | $656.1K |
| 2 | Berkley Neil Lindsay | Chief Bus Ofcr, Interim CFO | — | $220.8K |
| 3 | Wong-Sarad Grace | Principal Accounting Off | — | $99.0K |
| 4 | Kenkare-Mitra Sara | Pres, Head of R, D | — | $46.7K |
| 5 | GAROFALO ELIZABETH A. | Dir | — | — |
| 6 | Hammond Paula | Dir | — | — |
| 7 | Yaffe Kristine | Dir | — | — |
| 8 | Altmeyer Mark | Dir | — | — |
| 9 | SCHELLER RICHARD H | Dir | — | — |
| 10 | LAVIGNE LOUIS J JR | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 16:05 | 2026-06-17 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | A - Grant | $0.00 | +28.7K | 118.7K | +32% | $0 |
| D | 2026-06-03 21:04 | 2026-06-01 | XENE | Xenon Pharmaceuticals Inc. | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +2,645 | 2,645 | New | — |
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +8,107 | 33.5K | +32% | — |
| 2025-09-03 | 2025-09-02 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | S - Sale | $25.98 | -1,600 | 25.4K | -6% | -$41.6K | |
| D | 2025-06-12 | 2025-06-11 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | A - Grant | $0.00 | +28.7K | 90.0K | +47% | $0 |
| D | 2025-06-02 | 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +9,387 | 27.0K | +53% | — |
| 2025-03-06 | 2025-03-05 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | S - Sale | $18.23 | -4,919 | 17.6K | -22% | -$89.7K | |
| 2024-06-12 | 2024-06-12 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | A - Grant | $0.00 | +35.0K | 61.2K | +133% | $0 | |
| D | 2024-05-31 | 2024-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +6,652 | 22.5K | +42% | — |
| D | 2024-03-11 | 2024-03-08 | XENE | Xenon Pharmaceuticals Inc. | GAROFALO ELIZABETH A. | Dir | M - OptEx | $18.56 | +3,500 | 3,500 | New | +$65.0K |
| D | 2024-03-11 | 2024-03-08 | XENE | Xenon Pharmaceuticals Inc. | GAROFALO ELIZABETH A. | Dir | S - Sale+OE | $45.69 | -2,092 | 0 | -100% | -$95.6K |
| D | 2024-03-11 | 2024-03-08 | XENE | Xenon Pharmaceuticals Inc. | GAROFALO ELIZABETH A. | Dir | F - Tax | $46.16 | -1,408 | 2,092 | -40% | -$65.0K |
| 2023-12-06 | 2023-12-05 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | G - Gift | $0.00 | -9,459 | 26.2K | -26% | $0 | |
| 2023-11-28 | 2023-11-24 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | G - Gift | $0.00 | -2,918 | 15.9K | -16% | $0 | |
| D | 2023-06-15 | 2023-06-14 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | A - Grant | $0.00 | +26.2K | 35.7K | +278% | $0 |
| DM | 2023-06-05 | 2022-06-07+ | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +16.9K | 8,309 | New | — |
| D | 2022-06-21 | 2022-06-16 | ALEC | Alector, Inc. | GAROFALO ELIZABETH A. | Dir | A - Grant | $0.00 | +9,459 | 9,459 | New | $0 |
| D | 2021-10-01 | 2021-09-29 | ACAD | ACADIA PHARMACEUTICALS INC | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +1,918 | 1,918 | New | — |
Purchase Sale Sale after option exercise All abbreviations